The veterinary medicine market accounted for USD 22,973 Million in 2019, and is expected to reach USD 29,698 Million by 2027, registering a CAGR of 4.6% from 2020 to 2027.
Veterinary medicine is termed as any product used to treat various medical conditions in animals. For instance, veterinary medicine include drugs such as anti-infective drugs and parasiticides, which are administered orally in animals. Similarly, veterinary medicine also includes vaccines, which are used to build immunity in animals against various infectious diseases such as equine influenza (EIV) and parainfluenza 3-respiratory syncytial. In addition, they also include medicated feed additives, which are mixed with animal feed to provide pharmaceutical effects in animals. Moreover, veterinary medicine is used in various type of animals including companion animals such as dogs and cats and livestock animals such as cattle, pigs, and poultry. Furthermore, the medicine is administered in animals via different routes such as drugs are manly administered through oral route, vaccines are given through parenteral route, and some parasiticidal drug preparations are administered through topical route.
Some medical conditions in animals that are treated using veterinary medicine include pain and inflammation associated with osteoarthritis, hookworm, whipworm, infections, and others.
The major factors that contribute toward the growth of the veterinary medicine market include rise in number of pet owners and surge in livestock population across the globe. Furthermore, factors such as surge in prevalence of various medical conditions in animals and rise in demand for livestock products also boost the veterinary medicine market growth. In addition, rise in animal healthcare expenditure is another major factor that fuels growth of the market. However, lack of veterinary infrastructure facilities in underdeveloped nations and stringent regulations associated with medicate feed additives restrict veterinary medicine market growth. Conversely, increase in awareness toward animal health offers a lucrative opportunity for the veterinary medicine market.
Moreover, COVID-19 pandemic has also affected the market adversely. For instance, after COVID-19 was declared as a pandemic by WHO, countries worldwide adopted nationwide lockdowns to observe social distancing as a measure to contain the spread. This lead to disruption, limitation, challenges and changes in each sector of every industry. Similarly, veterinary medicines industry was also impacted by the pandemic. For instance, veterinary organizations across the globe have recommended limiting animal patient care to acutely ill animals and emergencies. Furthermore, the lockdowns have led to rescheduling of annual checkup exams and elective procedures. However, various key players have ensured the supply of veterinary medicines as the governmental institutions across the globe are taking strict measures to maintain the supply. Therefore, overall impact of COVID-19 on the veterinary market remains fairly negative, owing to fall in demand as veterinary visits are limited and animal healthcare approach is changed to providing care to emergency cases and critically ill animals.
Veterinary Medicine Market Segmentation
The global veterinary medicine market is segmented on the basis of product, route of administration, animal type, distribution channel, and region to provide a detailed assessment of the market. By product, it is divided into drugs, vaccines, and medicated feed additives. The drugs segment is further divided into anti-infective, anti-inflammatory, and parasiticide. In addition, the vaccines segment is divided into inactivated vaccines, attenuated vaccines, and recombinant vaccines. Similarly, the medicated feed additives segment is divided into amino acids and antibiotics.
By route of administration, the market is classified into oral route, parenteral route, and topical route. By animal type, it is divided into companion animals and livestock animals. By distribution channel, it is classified into veterinary hospitals, veterinary clinics, and pharmacies & drug stores. By region, the veterinary medicine market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment Review
On the basis of product, the drugs segment held a dominant share in 2019, owing to factors such as rise in prevalence of parasites in animals and surge in prevalence of various infections, which are treated using anti-infective drugs. Furthermore, other factors that contribute to growth of the market include surge in awareness related to use of drugs in animals and rise in adoption of veterinary drugs across the globe.
By route of administration, the parenteral segment occupied largest share of the veterinary medicine market in 2019. Growth of this segment is attributed to large number of parenteral formulations offered by key players in the market. In addition, the topical segment exhibited the fastest growth as the key players have increased their focus toward launching novel topical products for treatment of parasites.
In 2019, North America accounted for major share of the veterinary medicine market size, and is expected to continue this trend, owing to surge in number of companion animal owners and easy availability of veterinary medicines. Moreover, other factors such as surge in animal health expenditure also boost growth of the veterinary medicine market in the region. Asia-Pacific is expected to exhibit fastest growth rate, owing to surge in awareness related to use of veterinary medicines. Other factors that boost growth of the market include surge in awareness related to animal health and rise in ownership of companion animals in the region.
The global veterinary medicine market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum veterinary medicine market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Zoetis, Inc., Merck & Co., Inc. (Intervet International B.V.), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Santé Animale, Virbac., Vetoquinol S.A., Boehringer Ingelheim International GmbH., ADM Animal Nutrition, and Evonik Industries AG.
Key Benefits For Stakeholders
Key Market Segments
By Product
By Route of Administration
By Route of Administration
By Animal Type
By Distribution Channel
By Region
TABLE OF CONTENT
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping veterinary medicines industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in ownership of companion animals
3.4.1.2.Rise in livestock population across the globe
3.4.1.3.Rise in animal healthcare expenditure
3.4.1.4.Surge in prevalence of various medical conditions in animals
3.4.2.Restraint
3.4.2.1.Stringent regulatory approvals related to veterinary drugs and vaccines
3.4.2.2.Lack of veterinary infrastructure facilities in underdeveloped nations
3.4.3.Opportunity
3.4.3.1.Surge in awareness related to animal healthcare
3.4.4.Impact Analyses
3.5.Covid-19 impact analysis on global veterinary medicine market
CHAPTER 4:VETERINARY MEDICINE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Drugs
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Anti-infective
4.2.2.1.1.Market size and forecast
4.2.2.2.Anti-inflammatory
4.2.2.2.1.Market size and forecast
4.2.2.3.Parasiticide
4.2.2.3.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Vaccines
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Inactivated Vaccines
4.3.2.1.1.Market size and forecast
4.3.2.2.Attenuated Vaccines
4.3.2.2.1.Market size and forecast
4.3.2.3.Recombinant Vaccines
4.3.2.3.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Medicated feed additives
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
4.4.2.1.Amino Acids
4.4.2.1.1.Market size and forecast
4.4.2.2.Antibiotics
4.4.2.2.1.Market size and forecast
4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country
CHAPTER 5:VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINSTRATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Oral route
5.2.1.Market size and forecast, by region
5.2.2.Market analysis by country
5.3.Parenteral route
5.3.1.Market size and forecast, by region
5.3.2.Market analysis by country
5.4.Topical route
5.4.1.Market size and forecast, by region
5.4.2.Market analysis by country
CHAPTER 6:VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
6.1.Overview
6.1.1.Market size and forecast
6.2.Companion animal
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Livestock animals
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
CHAPTER 7:VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
7.1.Overview
7.1.1.Market size and forecast
7.2.Veterinary hospital pharmacies
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Retail veterinary pharmacies
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
CHAPTER 8:VETERINARY MEDICINE MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.Market analysis, by country
8.2.2.1.U.S.
8.2.2.1.1.U.S. market size and forecast, by product
8.2.2.1.2.U.S. market size and forecast, by route of administration
8.2.2.1.3.U.S. market size and forecast, by animal type
8.2.2.1.4.U.S. market size and forecast, by distribution channel
8.2.2.2.Canada
8.2.2.2.1.Canada market size and forecast, by product
8.2.2.2.2.Canada market size and forecast, by route of administration
8.2.2.2.3.Canada market size and forecast, by animal type
8.2.2.2.4.Canada market size and forecast, by distribution channel
8.2.2.3.Mexico
8.2.2.3.1.Mexico market size and forecast, by product
8.2.2.3.2.Mexico market size and forecast, by route of administration
8.2.2.3.3.Mexico market size and forecast, by animal type
8.2.2.3.4.Mexico market size and forecast, by distribution channel
8.2.3.North America market size and forecast, by product
8.2.4.North America market size and forecast, by route of administration
8.2.5.North America market size and forecast, by animal type
8.2.6.North America market size and forecast, by distribution channel
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Market analysis, by country
8.3.2.1.Germany
8.3.2.1.1.Germany market size and forecast, by product
8.3.2.1.2.Germany market size and forecast, by route of administration
8.3.2.1.3.Germany market size and forecast, by animal type
8.3.2.1.4.Germany market size and forecast, by distribution channel
8.3.2.2.France
8.3.2.2.1.France market size and forecast, by product
8.3.2.2.2.France market size and forecast, by route of administration
8.3.2.2.3.France market size and forecast, by animal type
8.3.2.2.4.France market size and forecast, by distribution channel
8.3.2.3.UK
8.3.2.3.1.UK market size and forecast, by product
8.3.2.3.2.UK market size and forecast, by route of administration
8.3.2.3.3.UK market size and forecast, by animal type
8.3.2.3.4.UK market size and forecast, by distribution channel
8.3.2.4.Italy
8.3.2.4.1.Italy market size and forecast, by product
8.3.2.4.2.Italy market size and forecast, by route of administration
8.3.2.4.3.Italy market size and forecast, by animal type
8.3.2.4.4.Italy market size and forecast, by distribution channel
8.3.2.5.Spain
8.3.2.5.1.Spain market size and forecast, by product
8.3.2.5.2.Spain market size and forecast, by route of administration
8.3.2.5.3.Spain market size and forecast, by animal type
8.3.2.5.4.Spain market size and forecast, by distribution channel
8.3.2.6.Rest of Europe
8.3.2.6.1.Rest of Europe market size and forecast, by product
8.3.2.6.2.Rest of Europe market size and forecast, by route of administration
8.3.2.6.3.Rest of Europe market size and forecast, by animal type
8.3.2.6.4.Rest of Europe market size and forecast, by distribution channel
8.3.3.Europe market size and forecast, by product
8.3.4.Europe market size and forecast, by route of administration
8.3.5.Europe market size and forecast, by animal type
8.3.6.Europe market size and forecast, by distribution channel
8.4.Asia-Pacific
8.4.1.Key market trends and opportunities
8.4.2.Market analysis, by country
8.4.2.1.Japan
8.4.2.1.1.Japan market size and forecast, by product
8.4.2.1.2.Japan market size and forecast, by route of administration
8.4.2.1.3.Japan market size and forecast, by animal type
8.4.2.1.4.Japan market size and forecast, by distribution channel
8.4.2.2.China
8.4.2.2.1.China market size and forecast, by product
8.4.2.2.2.China market size and forecast, by route of administration
8.4.2.2.3.China market size and forecast, by animal type
8.4.2.2.4.China market size and forecast, by distribution channel
8.4.2.3.Australia
8.4.2.3.1.Australia market size and forecast, by product
8.4.2.3.2.Australia market size and forecast, by route of administration
8.4.2.3.3.Australia market size and forecast, by animal type
8.4.2.3.4.Australia market size and forecast, by distribution channel
8.4.2.4.India
8.4.2.4.1.India market size and forecast, by product
8.4.2.4.2.India market size and forecast, by route of administration
8.4.2.4.3.India market size and forecast, by animal type
8.4.2.4.4.India market size and forecast, by distribution channel
8.4.2.5.South Korea
8.4.2.5.1.South Korea market size and forecast, by product
8.4.2.5.2.South Korea market size and forecast, by route of administration
8.4.2.5.3.South Korea market size and forecast, by animal type
8.4.2.5.4.South Korea market size and forecast, by distribution channel
8.4.2.6.Rest of Asia-Pacific
8.4.2.6.1.Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2.Rest of Asia-Pacific market size and forecast, by route of administration
8.4.2.6.3.Rest of Asia-Pacific market size and forecast, by animal type
8.4.2.6.4.Rest of Asia-Pacific market size and forecast, by distribution channel
8.4.3.Asia-Pacific market size and forecast, by product
8.4.4.Asia-Pacific market size and forecast, by route of administration
8.4.5.Asia-Pacific market size and forecast, by animal type
8.4.6.Asia-Pacific market size and forecast, by distribution channel
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.Market analysis, by country
8.5.2.1.Brazil
8.5.2.1.1.Brazil market size and forecast, by product
8.5.2.1.2.Brazil market size and forecast, by route of administration
8.5.2.1.3.Brazil market size and forecast, by animal type
8.5.2.1.4.Brazil market size and forecast, by distribution channel
8.5.2.2.Saudi Arabia
8.5.2.2.1.Saudi Arabia market size and forecast, by product
8.5.2.2.2.Saudi Arabia market size and forecast, by route of administration
8.5.2.2.3.Saudi Arabia market size and forecast, by animal type
8.5.2.2.4.Saudi Arabia market size and forecast, by distribution channel
8.5.2.3.South Africa
8.5.2.3.1.South Africa market size and forecast, by product
8.5.2.3.2.South Africa market size and forecast, by route of administration
8.5.2.3.3.South Africa market size and forecast, by animal type
8.5.2.3.4.South Africa market size and forecast, by distribution channel
8.5.2.4.Rest of LAMEA
8.5.2.4.1.Rest of LAMEA market size and forecast, by product
8.5.2.4.2.Rest of LAMEA market size and forecast, by route of administration
8.5.2.4.3.Rest of LAMEA market size and forecast, by animal type
8.5.2.4.4.Rest of LAMEA market size and forecast, by distribution channel
8.5.3.LAMEA market size and forecast, by product
8.5.4.LAMEA market size and forecast, by route of administration
8.5.5.LAMEA market size and forecast, by animal type
8.5.6.LAMEA market size and forecast, by distribution channel
CHAPTER 9:COMPANY PROFILES
9.1.Archer Daniels Midland
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.Boehringer Ingelheim International GmbH
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.Ceva Santé Animale
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.4.Dechra Pharmaceuticals PLC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.Elanco Animal Health Incorporated.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance.
9.5.6.Key strategic moves and developments
9.6.Evonik Industries AG (RAG Stiftung)
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.Merck & Co., Inc.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.Soparfin SCA.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Key strategic moves and developments
9.9.Virbac SA.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.Zoetis Inc.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
LIST OF TABLES & FIGURES
TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLIONS)
TABLE 02.POPULATION OF CATS AND DOGS IN EUROPEAN COUNTRIES, 2018
TABLE 03.MAJOR SPECIES OF LIVESTOCK POPULATION IN INDIA, 2012 & 2019 (IN MILLION)
TABLE 04.PARASITE DISEASES & THEIR PREVALENCE IN U.S., 2019
TABLE 05.VETERINARY MEDICINE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 06.VETERINARY MEDICINE MARKET FOR DRUGS, BY TYPE, 2019–2027($MILLION)
TABLE 07.ANTI-INFECTIVE MARKET, 2019–2027 ($MILLION)
TABLE 08.ANTI-INFLAMMATORY MARKET, 2019–2027 ($MILLION)
TABLE 09.PARASITICIDE MARKET, 2019–2027 ($MILLION)
TABLE 10.VETERINARY MEDICINE MARKET FOR DRUGS, BY REGION 2019–2027($MILLION)
TABLE 11.VETERINARY MEDICINE MARKET FOR VACCINES, BY TYPE 2019–2027($MILLION)
TABLE 12.INACTIVATED VACCINES MARKET, 2019–2027 ($MILLION)
TABLE 13.ATTENUATED VACCINES MARKET, 2019–2027 ($MILLION)
TABLE 14.RECOMBINANT VACCINES MARKET, 2019–2027 ($MILLION)
TABLE 15.VETERINARY MEDICINE MARKET FOR VACCINES, BY REGION 2019–2027($MILLION)
TABLE 16.VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY TYPE 2019–2027($MILLION)
TABLE 17.AMINO ACIDS MARKET, 2019–2027 ($MILLION)
TABLE 18.ANTIBIOTICS MARKET, 2019–2027 ($MILLION)
TABLE 19.VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY REGION 2019–2027($MILLION)
TABLE 20.VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2027 ($MILLION)
TABLE 21.VETERINARY MEDICINE MARKET FOR ORAL ROUTE, BY REGION 2019–2027C($MILLION)
TABLE 22.VETERINARY MEDICINE MARKET FOR PARENTERAL ROUTE, BY REGION 2019–2027 ($MILLION)
TABLE 23.VETERINARY MEDICINE MARKET FOR TOPICAL ROUTE, BY REGION 2019–2027 ($MILLION)
TABLE 24.VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2019-2027 ($MILLION)
TABLE 25.VETERINARY MEDICINE MARKET FOR COMPANION ANIMALS, BY REGION 2019–2027($MILLION)
TABLE 26.VETERINARY MEDICINE MARKET FOR LIVESTOCK ANIMALS, BY REGION 2019–2027 ($MILLION)
TABLE 27.VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 28.VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITAL PHARMACIES, BY REGION 2019–2027($MILLION)
TABLE 29.VETERINARY MEDICINE MARKET FOR RETAIL VETERINARY PHARMACIES, BY REGION 2019–2027 ($MILLION)
TABLE 30.VETERINARY MEDICINE MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 31.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020–2027 ($MILLION)
TABLE 32.U.S. VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 33.U.S. VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 34.U.S. VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 35.U.S. VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 36.CANADA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 37.CANADA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 38.CANADA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 39.CANADA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 40.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 41.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 42.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 43.MEXICO VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 44.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027($MILLION)
TABLE 45.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 46.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 47.NORTH AMERICA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027($MILLION)
TABLE 48.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020–2027 ($MILLION)
TABLE 49.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 50.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 51.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 52.GERMANY VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 53.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 54.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 55.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 56.FRANCE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 57.UK VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 58.UK VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 59.UK VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 60.UK VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 61.ITALY VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 62.ITALY VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 63.ITALY VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 64.ITALY VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 65.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 66.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 67.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 68.SPAIN VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 69.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 70.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 71.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 72.REST OF EUROPE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 73.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027($MILLION)
TABLE 74.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 75.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 76.EUROPE VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027($MILLION)
TABLE 77.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020–2027 ($MILLION)
TABLE 78.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 79.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 80.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 81.JAPAN VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 82.CHINA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 83.CHINA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 84.CHINA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 85.CHINA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 86.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 87.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 88.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 89.AUSTRALIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 90.INDIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 91.INDIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 92.INDIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 93.INDIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 94.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 95.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 96.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 97.SOUTH KOREA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 98.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 99.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 100.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 101.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 102.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027($MILLION)
TABLE 103.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 104.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 105.ASIA-PACIFIC VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027($MILLION)
TABLE 106.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY COUNTRY, 2020–2027 ($MILLION)
TABLE 107.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 108.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 109.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 110.BRAZIL VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 111.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 112.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 113.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 114.SAUDI ARABIA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 115.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 116.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 117.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 118.SOUTH AFRICA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 119.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027 ($MILLION)
TABLE 120.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027 ($MILLION)
TABLE 121.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ANIMAL TYPE, 2020–2027 ($MILLION)
TABLE 122.REST OF LAMEA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027 ($MILLION)
TABLE 123.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY PRODUCT, 2020–2027($MILLION)
TABLE 124.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 125.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY ROUTE OF ADMINISTRATION, 2020–2027($MILLION)
TABLE 126.LAMEA VETERINARY MEDICINE MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2020–2027($MILLION)
TABLE 127.ADM: COMPANY SNAPSHOT
TABLE 128.ADM: OERATING SEGMENT
TABLE 129.ADM: PRODUCT PORTFOLIO
TABLE 130.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 131.BOEHRINGER INGELHEIM: PRODUCT BUSINESS SEGMENTS
TABLE 132.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 133.CEVA: COMPANY SNAPSHOT
TABLE 134.CEVA: OPERATING SEGMENTS
TABLE 135.CEVA: PRODUCT PORTFOLIO
TABLE 136.DECHRA: COMPANY SNAPSHOT
TABLE 137.DECHRA: OPERATING BUSINESS SEGMENTS
TABLE 138.DECHRA: PRODUCT PORTFOLIO
TABLE 139.ELANCO: COMPANY SNAPSHOT
TABLE 140.ELANCO: OPERATING SEGMENTS
TABLE 141.ELANCO: PRODUCT PORTFOLIO
TABLE 142.EVONIK: COMPANY SNAPSHOT
TABLE 143.EVONIK: OPERATING SEGMENTS
TABLE 144.EVONIK: PRODUCT PORTFOLIO
TABLE 145.MERCK.: COMPANY SNAPSHOT
TABLE 146.MERCK.: OPERATING SEGMENTS
TABLE 147.MERCK.: PRODUCT PORTFOLIO
TABLE 148.SOPARFIN: COMPANY SNAPSHOT
TABLE 149.SOPARFIN: PRODUCT SEGMENTS
TABLE 150.SOPARFIN: PRODUCT PORTFOLIO
TABLE 151.VIRBAC: COMPANY SNAPSHOT
TABLE 152.VIRBAC: OPERATING BUSINESS SEGMENTS
TABLE 153.VIRBAC: PRODUCT PORTFOLIO
TABLE 154.ZOETIS: COMPANY SNAPSHOT
TABLE 155.ZOETIS: OPERATING BUSINESS SEGMENTS
TABLE 156.ZOETIS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL VETERINARY MEDICINE MARKET SEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.HIGH THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.LOW THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSES, VETERINARY MEDICINE MARKET
FIGURE 10.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR DRUGS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 11.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR VACCINES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR MEDICATED FEED ADDITIVES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR ORAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR PARENTERAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR TOPICAL ROUTE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR VETERINARY HOSPITAL PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VETERINARY MEDICINE MARKET FOR RETAIL VETERIANRY PHARMACIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.U.S. VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 21.CANADA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 22.MEXICO VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 23.GERMANY VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 24.FRANCE VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 25.UK VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 26.ITALY VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 27.SPAIN VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 28.REST OF EUROPE VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 29.JAPAN VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 30.CHINA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 31.AUSTRALIA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 32.INDIA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 33.SOUTH KOREA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 34.REST OF ASIA-PACIFIC VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 35.BRAZIL VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 36.SAUDI ARABIA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 37.SOUTH AFRICA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 38.REST OF LAMEA VETERINARY MEDICINE MARKET, 2020–2027 ($MILLION)
FIGURE 39.ADM: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.ADM: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.ADM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.BOEHRINGER INGELHEIM: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.BOEHRINGER INGELHEIM: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 44.BOEHRINGER INGELHEIM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.DECHRA: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.DECHRA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.DECHRA: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 48.ELANCO: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.ELANCO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.ELANCO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.EVONIK: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.EVONIK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 53.MERCK.: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 55.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 56.VIRBAC: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.VIRBAC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 58.VIRBAC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 59.ZOETIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 60.ZOETIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 61.ZOETIS: REVENUE SHARE, BY REGION, 2019 (%)
$5769
$8995
HAVE A QUERY?
OUR CUSTOMER
Add to Cart
Add to Cart
Add to Cart
Add to Cart